BC Week In Review | Jun 1, 2018
Financial News

JHL raises $106M in bond deal

Biosimilars company JHL Biotech Inc. (Zhubei, Taiwan) raised $106 million on May 15 in convertible bonds led by new investor VMS Investment Group, according to JHL CFO Ellis Chu. Also participating were new investor Ruihua...
BC Extra | May 30, 2018
Financial News

JHL raises $106M in bond deal

Biosimilars company JHL Biotech Inc. (Zhubei, Taiwan) raised $106 million in convertible bonds led by new investor VMS Investment Group, according to JHL CFO Ellis Chu. Also participating were Ruihua Investment, existing investor Milestone Capital...
BC Week In Review | Dec 16, 2016
Company News

JHL, Sanofi deal

JHL granted Sanofi exclusive, Chinese development and commercialization rights to biosimilar rituximab (JHL1101). JHL will receive $21 million up front and is eligible for up to $236 million in milestones, plus royalties. Sanofi also invested...
BC Extra | Dec 5, 2016
Company News

Sanofi invests in JHL, gets biosimilar rights

JHL Biotech Inc. (TPex-E:6540) granted Sanofi (Euronext:SAN: NYSE:SNY) rights in China to develop and commercialize biosimilar rituximab ( JHL1101 ), as well as options for rights to other JHL candidates. JHL is to receive $21 million...
Items per page:
1 - 4 of 4